David Liliana, Brata Anca Monica, Mogosan Cristina, Pop Cristina, Czako Zoltan, Muresan Lucian, Ismaiel Abdulrahman, Dumitrascu Dinu Iuliu, Leucuta Daniel Corneliu, Stanculete Mihaela Fadygas, Iaru Irina, Popa Stefan Lucian
2nd Medical Department, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400000 Cluj-Napoca, Romania.
Faculty of Environmental Protection, University of Oradea, 410048 Oradea, Romania.
Antibiotics (Basel). 2021 Nov 10;10(11):1376. doi: 10.3390/antibiotics10111376.
Over recent decades, a new antibiotic crisis has been unfolding due to a decreased research in this domain, a low return of investment for the companies that developed the drug, a lengthy and difficult research process, a low success rate for candidate molecules, an increased use of antibiotics in farms and an overall inappropriate use of antibiotics. This has led to a series of pathogens developing antibiotic resistance, which poses severe threats to public health systems while also driving up the costs of hospitalization and treatment. Moreover, without proper action and collaboration between academic and health institutions, a catastrophic trend might develop, with the possibility of returning to a pre-antibiotic era. Nevertheless, new emerging AI-based technologies have started to enter the field of antibiotic and drug development, offering a new perspective to an ever-growing problem. Cheaper and faster research can be achieved through algorithms that identify hit compounds, thereby further accelerating the development of new antibiotics, which represents a vital step in solving the current antibiotic crisis. The aim of this review is to provide an extended overview of the current artificial intelligence-based technologies that are used for antibiotic discovery, together with their technological and economic impact on the industrial sector.
近几十年来,由于该领域研究减少、药物研发公司投资回报率低、研究过程漫长且艰难、候选分子成功率低、农场抗生素使用增加以及抗生素整体使用不当,一场新的抗生素危机正在显现。这导致一系列病原体产生抗生素耐药性,对公共卫生系统构成严重威胁,同时也推高了住院和治疗成本。此外,如果学术机构和卫生机构之间没有采取适当行动和开展合作,可能会出现灾难性趋势,有可能回到抗生素出现之前的时代。然而,新兴的基于人工智能的技术已开始进入抗生素和药物研发领域,为这个日益严重的问题提供了新视角。通过识别活性化合物的算法可以实现更廉价、更快速的研究,从而进一步加速新型抗生素的研发,这是解决当前抗生素危机的关键一步。本综述的目的是全面概述当前用于抗生素发现的基于人工智能的技术,以及它们对工业部门的技术和经济影响。